Essential Hypertension: When Lifestyle Modification Has Not Achieved Blood Pressure Goals
Previous step — insufficient response
A structured programme of lifestyle and psychosocial modification — encompassing dietary adjustment, sodium restriction, increased physical activity, potassium intake, alcohol reduction, and stress management — did not lower blood pressure to the target of <130/80 mm Hg after a 3-to-6-month trial.
Clinical Scenario
An adult with confirmed essential hypertension has completed a sustained non-pharmacological management trial without reaching blood pressure goals. Evidence-based guidelines call for initiation of antihypertensive drug therapy as the next step to reduce cardiovascular risk.
Blood Pressure Targets
The protocol aims for a systolic blood pressure (SBP) of at least <130 mm Hg — with encouragement to reach SBP <120 mm Hg — and a diastolic blood pressure (DBP) below 80 mm Hg. Response is reassessed at approximately one month.
Treatment Direction (Partial Overview)
The protocol specifies established first-line antihypertensive drug classes and provides guidance on how the initial regimen is structured based on the patient's blood pressure level. Whether one or more agents are used, and how they are selected and combined, depends on factors detailed in the full protocol.
References
DOI: 10.1161/CIR.0000000000001356
- For adults initiating antihypertensive drug therapy, thiazide-type diuretics, long-acting dihydropyridine CCB, and ACEi or ARB are recommended as first-line therapy to prevent CVD.
- In adults with stage 2 hypertension (SBP ≥140 mm Hg and DBP ≥90 mm Hg), initiation of antihypertensive drug therapy with 2 first-line agents of different classes, ideally in a single-pill combination (SPC), is recommended to improve BP control and adherence.
- In adults with stage 1 hypertension (SBP 130–139 mm Hg and DBP 80–89 mm Hg), initiation of antihypertensive drug therapy with a single first-line antihypertensive drug is reasonable, with dosage titration and sequential addition of other agents as needed to achieve BP control.
- In adults with confirmed hypertension who are at increased risk for CVD, an SBP goal of at least <130 mm Hg, with encouragement to achieve SBP <120 mm Hg, is recommended to reduce the risk of cardiovascular events and total mortality.
- In adults with confirmed hypertension who are at increased risk for CVD, a DBP target of <80 mm Hg is recommended to reduce the risk of cardiovascular events and total mortality.
View source ↗